AERIE PHARMACEUTICALS INC 3 SEC Filings

Filed On	Filing
22 Mar 2022	Form 3: Lang Peter Frederick, Chief Financial Officer No securities owned
22 Dec 2021	Form 3: Kannan Raj, Director No securities owned
08 Nov 2021	Form 3: Calabrese Jeffrey, Vice President of Finance Holds 8,019 shares of Common Stock
18 Oct 2021	Form 3: Mcginley Kathleen, CHRO & VP, Corp Services Holds 24,871 shares of Common Stock
05 Aug 2021	Form 3: Staten Christopher, Interim CFO Holds 22,587 shares of Common Stock
11 Jun 2020	Form 3: McDonnell Peter J, Director No securities owned
13 Nov 2019	Form 3: Hollander David, Chief R&D Officer No securities owned
14 Aug 2019	Form 3: Foresite Capital Management II, Llc, 10% owner and 6 others Holds 1,672,714 shares of Common Stock
12 Sep 2018	Form 3: Gryska David W, Director Holds 1,996 shares of Common Stock
23 Jul 2018	Form 3: Flynn James E, 10% owner and 6 others Holds 3,866,001 shares of Common Stock
21 Feb 2018	Form 3: LaRocca John, General Counsel No securities owned
31 May 2017	Form 3: Foresite Capital Management II, Llc, 10% owner and 4 others Holds 1,682,532 shares of Common Stock
26 Jul 2016	Form 3: Foresite Capital Management II, Llc, 10% owner and 4 others Holds 1,672,714 shares of Common Stock
06 Jul 2015	Form 3: McHugh Julie, Director No securities owned
01 Jul 2015	Form 3: du Toit Michael, Director No securities owned
11 May 2015	Form 3: Croarkin Richard, Director No securities owned
10 Oct 2014	Form 3: Mcgraw Benjamin F Iii, Director No securities owned
13 Jun 2014	Form 3: Mazzo James V, Director No securities owned
25 Oct 2013	Form 3: Tpg Group Holdings (SBS) Advisors, Inc., 10% owner and 2 others
25 Oct 2013	Form 3: Duyk Geoffrey M, Director Holds 0 shares of No securities beneficially owned

Comments